Trademark search for:

INDALIFO

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2022-04-13 — Application filed
2022-04-16 — Application filed
2022-04-19 — Application filed
2022-10-19 — Assigned to examiner
2022-10-26 — Final disposition recorded
2022-10-26 — Final disposition recorded
2022-10-26 — Final disposition recorded
2023-04-26 — Office action issued
2023-04-26 — Correspondence received in law office
2023-04-27 — Teas/email correspondence entered
2023-05-01 — Examiners amendment -written
2023-05-01 — Approved for pub - principal register
2023-05-01 — Examiners amendment e-mailed
2023-05-01 — Notification of examiners amendment e-mailed
2023-05-01 — Examiner's amendment entered
2023-05-17 — Notification of notice of publication e-mailed
2023-06-06 — Published for opposition
2023-06-06 — Official gazette publication confirmation e-mailed
2023-08-01 — Noa e-mailed - sou required from applicant
2024-03-04 — Application abandoned
2024-03-04 — Application abandoned
2024-03-04 — Final status recorded

Owner Information

Iovance Biotherapeutics, Inc.
San Carlos , CA

Correspondent

Carla B. Oakley MORGAN, LEWIS & BOCKIUS LLP
ONE MARKET, SPEAR STREET TOWER
SAN FRANCISCO, CA 94105
UNITED STATES

Filing Details

Filing Date:
2022-04-13

Status Date:
2024-03-04

Category:
Pharmaceuticals

Filing Year:
2018

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.